Pet Med Express (NASDAQ: PETSGet a rating) and general cannabis (OTCMKTS: CANGet a rating) are both small cap retail/wholesale companies, but which is the better company? We’ll compare the two companies based on their risk strength, institutional ownership, profitability, earnings, valuation, dividends, and analyst recommendations.

Analyst Recommendations

This is a summary of the current recommendations for PetMed Express and General Cannabis, as provided by MarketBeat.com.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
Pet Med Express 1 1 1 0 2.00
General Cannabis 0 0 0 0 N / A

PetMed Express currently has a consensus price target of $27.00, indicating a potential upside of 10.66%. Considering the higher possible benefit of PetMed Express, research analysts clearly believe that PetMed Express is more favorable than General Cannabis.

Insider and Institutional Ownership

80.5% of PetMed Express shares are held by institutional investors. 2.9% of PetMed Express stock is held by insiders of the company. By comparison, 38.0% of General Cannabis stock is held by insiders of the company. Strong institutional ownership indicates that endowments, hedge funds, and large fund managers believe a company will outperform the market over the long term.

Valuation and benefits

This table compares revenue, earnings per share (EPS), and valuation of PetMed Express and General Cannabis.

Gross revenue Price/sales ratio Net revenue Earnings per share Price/earnings ratio
Pet Med Express $309.21 million 1.66 $30.60 million $1.08 22.59
General Cannabis $5.93 million 6.69 -8.87 million dollars N / A N / A

PetMed Express has higher revenue and profits than General Cannabis.

Profitability

This chart compares the net margins, return on equity, and return on assets of PetMed Express and General Cannabis.

Net margins Return on equity return on assets
Pet Med Express 7.83% 16.00% 13.11%
General Cannabis -149.64% -128.29% -46.38%

Volatility and risk

PetMed Express has a beta of 0.45, indicating its stock price is 55% less volatile than the S&P 500. In comparison, General Cannabis has a beta of 0.75, indicating its stock price is 25% less volatile than the S&P 500.

Summary

PetMed Express beats General Cannabis on 8 out of 11 factors compared between the two stocks.

PetMed Express Company Profile (Get a rating)

PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and over-the-counter pet medications, as well as other health products for dogs, cats and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products and supplies; and prescription medications, including heartworm, flea and tick preventative medications, arthritis, dermatitis, thyroid, diabetes, painkillers, blood pressure and heart, and other specialty medications , as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers and other pet supplies. It sells its products through its website and mobile application; telephone contact center; and direct mail/printing through catalogues, brochures and postcards. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

General Cannabis Business Profile (Get a rating)

General Cannabis Corp provides products and services to the regulated cannabis industry and non-cannabis customers in the United States. The Company operates in three segments: Operations, Culture and Investments. The Operations segment provides advisory services to the cannabis industry including licensing, compliance, cultivation, retail operations, logistics support, facility design and construction, and expansion. existing operations. This segment also provides supply and storage services to cultivation, retail and infused product manufacturing facilities. The Cultivation segment operates 17,000 square feet of licensed light deprivation greenhouse cultivation facilities. The Investments segment provides debt or equity capital to cannabis businesses by investing in businesses. The company was formerly known as Advanced Cannabis Solutions, Inc. and changed its name to General Cannabis Corp in June 2015. General Cannabis Corp was incorporated in 2013 and is headquartered in Denver, Colorado.



Get news and reviews for PetMed Express Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for PetMed Express and related companies with MarketBeat.com’s free daily email newsletter.